(Q42506981)

1 November 2017

title

Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma (English)

1 reference

1 November 2017

Jäckel MC

1

1 reference

1 November 2017

Mitteldorf C

series ordinal

2

1 reference

1 November 2017

Schweyer S

series ordinal

3

1 reference

1 November 2017

Füzesi L

series ordinal

4

1 reference

1 November 2017

publication date

1 August 2001

1 reference

1 November 2017

1 reference

1 November 2017

volume

23

1 reference

1 November 2017

issue

8

1 reference

1 November 2017

page(s)

646-652

1 reference

Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.

1 November 2017

cites work

1 reference

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms

21 January 2018

1 reference

Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.

21 January 2018

1 reference

CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95).

21 January 2018

1 reference

The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis

21 January 2018

1 reference

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance

21 January 2018

1 reference

Prognostic relevance of altered Fas (CD95)-system in human breast cancer

21 January 2018

1 reference

Localization of Fas antigen in oral squamous cell carcinoma

21 January 2018

1 reference

Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma

21 January 2018

1 reference

IFN-gamma-dependent delay of in vivo tumor progression by Fas overexpression on murine renal cancer cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HED.1091

1 reference

1 November 2017

1 reference